Bevacizumab Combined With Fractionated Stereotactic Radiotherapy for 1 to 10 Brain Metastases From NSCLC
Clinical trial NCT04345146 · COMPLETED
Trial details
- NCT number
- NCT04345146
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2023-03-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.